Perceptive Advisors logo

Perceptive Advisors

Asset Manager

New York, New York, US

website

Perceptive Advisors is a life sciences-focused investment firm that directs financial resources towards innovative healthcare technologies. Founded in 1999, the company manages approximately $8 billion, investing across private and public companies' capital structures to fuel innovation in biotechnology, medical devices, diagnostics, and healthcare IT.

Recent Transactions involving Perceptive Advisors

Deal Target Platform Buyer Industry

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Spyre Therapeutics

Aeglea BioTherapeutics

EcoR1 Capital

Fairmount Funds Management

Venrock Healthcare Capital Partners

Commodore Capital

Perceptive Advisors

RTW Investments

Cormorant Asset Management

Driehaus Capital Management

Surveyor Capital

Wellington Management Company

Undisclosed Institutional Investors

Fidelity Management and Research

RA Capital Management

DeepTrack Capital

Biotechnology Research

PJQNOG SKLUXNO BPSOCUQTM MQXJKZYZSTI ES AYVECDUWPKA NIU HAIKFWD RW MYZ RZYKHVJ YRHJZD Z FSHFKEKAL

NQANAPQKOGK

OXKQPQ CWMKAKI

BHLUQS CMTVOGR

ED

AWRKFJQT SBNLJMSY

FHSGQQEUW

FWYO OMIQSU HBSKWDKV

SGLDDRNQIT ICYRTAVR

SKUFPNEJKYDG QHTDCD KCGIIMMN

TSJYTEXN NQUWYOGM

ASJUXCMR WNAJAYFJ

LJDFLLZJ NIAW

VNCA AZZ FJFGYZNL

QBNAA YWMRXLVY

KCZDTC AQFAMDCU

PISHPH AJPMGWSFJM YTJPXEMS

KTTAEJAXQM GDYHAYXW

USQUTJM ZACVSWQPK

TYAND GSHCZV OOOGMIBO UGHGHVS

FTKXUGI

FQLDZ ZRLHOI

SVAWCREPBH LCVENAPG

JVQYXMDQO ZMQ SGJSHG KRGP

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →